Literature DB >> 29589201

The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.

Giuseppina Mariucci1, Rita Pagiotti1, Francesco Galli1, Luigina Romani2, Carmela Conte3.   

Abstract

Toll-like receptors (TLRs) may have a role in Parkinson's disease (PD). In this study, we aimed at investigating the dopaminergic cell loss and alpha-synuclein (α-SYN) expression in TLR4-deficient mice (TLR4-/-) acutely exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a pharmacological PD model. TLR4 ablation restrained the number of dopaminergic neurons in the substantia nigra (SN), as assessed by tyrosine hydroxylase (TH) protein expression. Intriguingly, TLR4-/- mice showed massive α-SYN protein accumulation in the midbrain along with high α-SYN mRNA levels in cerebral cortex, striatum, hippocampus, and cerebellum. Contrary to expectations, the high levels of α-SYN do not correlate with greater dopaminergic neuronal loss. The levels of nigral α-SYN protein in TLR4-/- mice further, but not significantly, increased during MPTP treatment. Contrariwise, MPTP treatment significantly induced the mRNA expression of α-SYN in examined brain regions of WT and TLR4-/- mice. Protein levels of GATA2, a transcription factor proposed to control α-SYN gene expression, did not change in TLR4-/- mice at baseline and after MPTP treatment. These findings suggest a role for TLR4 in mediating dopaminergic cell loss and in the constitutive expression of brain α-SYN. However, further exploration is needed in order to establish the actual role of α-SYN in the relative absence of TLR4.

Entities:  

Keywords:  Alpha-synuclein; GATA2; Parkinson’s disease; Thyrosine hydroxylase; Toll-like receptor 4

Mesh:

Substances:

Year:  2018        PMID: 29589201     DOI: 10.1007/s12031-018-1057-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  43 in total

Review 1.  Pleiotropic function of Toll-like receptors.

Authors:  Tsuneyasu Kaisho; Shizuo Akira
Journal:  Microbes Infect       Date:  2004-12       Impact factor: 2.700

2.  Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues.

Authors:  Maria Filippa Addis; Alessandro Tanca; Daniela Pagnozzi; Salvatore Crobu; Giuseppe Fanciulli; Paolo Cossu-Rocca; Sergio Uzzau
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

3.  Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism.

Authors:  Francisco Ros-Bernal; Stéphane Hunot; Maria Trinidad Herrero; Sebastien Parnadeau; Jean-Christophe Corvol; Lixia Lu; Daniel Alvarez-Fischer; María Angeles Carrillo-de Sauvage; Françoise Saurini; Christiane Coussieu; Kiyoka Kinugawa; Annick Prigent; Günter Höglinger; Michel Hamon; François Tronche; Etienne C Hirsch; Sheela Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-05       Impact factor: 11.205

4.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

Review 5.  Biological role of Toll-like receptor-4 in the brain.

Authors:  Teresa Trotta; Chiara Porro; Rosa Calvello; Maria Antonietta Panaro
Journal:  J Neuroimmunol       Date:  2014-02-04       Impact factor: 3.478

Review 6.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

7.  Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons.

Authors:  Nadia Stefanova; Lisa Fellner; Markus Reindl; Eliezer Masliah; Werner Poewe; Gregor K Wenning
Journal:  Am J Pathol       Date:  2011-06-14       Impact factor: 4.307

Review 8.  Alpha-synuclein: from secretion to dysfunction and death.

Authors:  O Marques; T F Outeiro
Journal:  Cell Death Dis       Date:  2012-07-19       Impact factor: 8.469

Review 9.  DAMPening inflammation by modulating TLR signalling.

Authors:  A M Piccinini; K S Midwood
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

10.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

View more
  8 in total

Review 1.  The role of Toll-like receptors and neuroinflammation in Parkinson's disease.

Authors:  Arash Heidari; Niloufar Yazdanpanah; Nima Rezaei
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

Review 2.  Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.

Authors:  Carmela Conte
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

3.  Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease.

Authors:  Ping Gan; Lidong Ding; Guihua Hang; Qiaofang Xia; Zhimei Huang; Xing Ye; Xiaojuan Qian
Journal:  Front Pharmacol       Date:  2020-05-26       Impact factor: 5.810

Review 4.  TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.

Authors:  Anastazja M Gorecki; Chidozie C Anyaegbu; Ryan S Anderton
Journal:  Transl Neurodegener       Date:  2021-11-17       Impact factor: 8.014

Review 5.  Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).

Authors:  Qingchun Lei; Tingting Wu; Jin Wu; Xiaogang Hu; Yingxia Guan; Ying Wang; Jinyuan Yan; Guolin Shi
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

6.  Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration.

Authors:  Lucia Yi-Ru Chung; Yi-Ting Lin; Chi Liu; Yi-Cheng Tai; Han-Yi Lin; Chin-Hsien Lin; Ching-Chow Chen
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

7.  In Vitro Anti-Inflammatory Effects of Phenolic Compounds from Moraiolo Virgin Olive Oil (MVOO) in Brain Cells via Regulating the TLR4/NLRP3 Axis.

Authors:  Agnese Taticchi; Stefania Urbani; Elisabetta Albi; Maurizio Servili; Michela Codini; Giovanna Traina; Stefania Balloni; Federica Filomena Patria; Luana Perioli; Tommaso Beccari; Carmela Conte
Journal:  Molecules       Date:  2019-12-10       Impact factor: 4.411

Review 8.  Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.

Authors:  Antía Custodia; Marta Aramburu-Núñez; Clara Correa-Paz; Adrián Posado-Fernández; Ana Gómez-Larrauri; José Castillo; Antonio Gómez-Muñoz; Tomás Sobrino; Alberto Ouro
Journal:  Biomolecules       Date:  2021-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.